Partners & Industrial Exhibition 2008
The Association for Immunotherapy of Cancer proudly presents its partners for the "CIMT 2008 - Industrial Exhibition"|
|
|
|
JPT Peptide Technologies is the leading provider of peptide microarrays, peptide pools and peptide libaries for applications in vaccine research, biomarker discovery and immune monitoring in clinical trials. JPT's peptide arrays (PepStarTM) are applied to study humoral immune responses in various patient populations on proteome wide levels. Our complementary peptide pools (PepMixTM) and peptide libraries (SPOTTM) are being used to systematically explore and monitor T-cell responses using common T-cell assays such as ELISPOT, CFC and others. JPT is committed to highest quality standards according to an DIN ISO 9001:2000 certified Quality Management System. |
|
|
|
|
|
|
|
|
 |
|
|
|
|
 |
|
|
|
|
 |
immatics biotechnologies is an independent biopharmaceutical company dedicated to the development of active immunotherapies against cancer. immatics' therapeutic vaccines are based on multiple tumor-associated peptides (TUMAPs) which specifically stimulate the immune system against cancer cells. The lead product IMA901 for therapy of renal cell cancer is currently investigated in an international phase II clinical study. Another multi-peptide-based vaccine for the treatment of colorectal cancer, IMA910, will soon enter clinical development. Since its foundation in 2000 immatics has raised over €54 million of venture capital in two financing rounds and employs more than 50 people in Tuebingen and Munich, Germany. |
|
|
|
 |
|
|
|
|
 |
|
|
|
|
 |
|
|
|
|
 |
Bio-Rad Laboratories has remained at the centre of scientific discovery
for more than 50 years by providing a broad range of innovative tools
and services to the clinical diagnostics and life science research
markets. It has built strong customer relationships that advance
research and support the development and refinement of new technology. One such product is the Bio-Plex® Suspension Array System: a flexible, easy-to-use multiplex analysis system that permits the simultaneous analysis of up to 100 different biomolecules (proteins, peptides, or nucleic acids) in a single microplate well. Multiplexing allows researchers to dramatically increase the amount of useful information from rare or volume-limited samples such as mouse or rat serum, and decipher complex interrelationships, for example, among proteins involved in signal transduction pathways. |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
CellGenix Technologie Transfer GmbH |
